These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12881196)

  • 1. Targeting of human squamous carcinomas by SPA470-doxorubicin immunoconjugates.
    Hebert C; Norris K; Sauk JJ
    J Drug Target; 2003 Feb; 11(2):101-7. PubMed ID: 12881196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates.
    Trail PA; Willner D; Knipe J; Henderson AJ; Lasch SJ; Zoeckler ME; TrailSmith MD; Doyle TW; King HD; Casazza AM; Braslawsky GR; Brown J; Hofstead SJ; Greenfield RS; Firestone RA; Mosure K; Kadow KF; Yang MB; Hellström KE; Hellström I
    Cancer Res; 1997 Jan; 57(1):100-5. PubMed ID: 8988048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
    Sinkule JA; Rosen ST; Radosevich JA
    Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The production of the endostatin precursor collagen XVIII in head and neck carcinomas is modulated by CBP2/Hsp47.
    Ollins GJ; Nikitakis N; Norris K; Herbert C; Siavash H; Sauk JJ
    Anticancer Res; 2002; 22(4):1977-82. PubMed ID: 12174873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and functional evaluation of new doxorubicin immunoconjugates containing an acid-sensitive linker on small-cell lung cancer cells.
    Froesch BA; Stahel RA; Zangemeister-Wittke U
    Cancer Immunol Immunother; 1996 Jan; 42(1):55-63. PubMed ID: 8625367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and in vitro anti-tumor activity of novel HPMA copolymer-drug conjugates with potential cell surface targeting property for carcinoma cells.
    Xiang Q; Yang Y; Zhou Z; Zhou D; Jin Y; Zhang Z; Huang Y
    Eur J Pharm Biopharm; 2012 Feb; 80(2):379-86. PubMed ID: 22101181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic efficacy of doxorubicin enzymatically assembled on galactose residues of a monoclonal antibody specific for the carcinoembryonic antigen.
    Stan AC; Radu DL; Casares S; Bona CA; Brumeanu TD
    Cancer Res; 1999 Jan; 59(1):115-21. PubMed ID: 9892195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
    Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
    King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
    Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting acute hypoxic cancer cells by doxorubicin-immunoliposomes directed by monoclonal antibodies specific to RON receptor tyrosine kinase.
    Guin S; Ma Q; Padhye S; Zhou YQ; Yao HP; Wang MH
    Cancer Chemother Pharmacol; 2011 May; 67(5):1073-83. PubMed ID: 20658288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Sp17 monoclonal antibody-doxorubicin conjugates as molecularly targeted chemotherapy for ovarian carcinoma.
    Song JX; Li FQ; Cao WL; Jia X; Shi LN; Lu JF; Ma CF; Kong QQ
    Target Oncol; 2014 Sep; 9(3):263-72. PubMed ID: 23943313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
    Fowers KD; Kopeček J
    Macromol Biosci; 2012 Apr; 12(4):502-14. PubMed ID: 22278817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.
    Ulbrich K; Etrych T; Chytil P; Jelínková M; Ríhová B
    J Control Release; 2003 Feb; 87(1-3):33-47. PubMed ID: 12618021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.
    Greenfield RS; Kaneko T; Daues A; Edson MA; Fitzgerald KA; Olech LJ; Grattan JA; Spitalny GL; Braslawsky GR
    Cancer Res; 1990 Oct; 50(20):6600-7. PubMed ID: 2208122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin immunoconjugates containing bivalent, lysosomally-cleavable dipeptide linkages.
    Dubowchik GM; Radia S; Mastalerz H; Walker MA; Firestone RA; Dalton King H; Hofstead SJ; Willner D; Lasch SJ; Trail PA
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1529-32. PubMed ID: 12031335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
    Vrouenraets MB; Visser GW; Stigter M; Oppelaar H; Snow GB; van Dongen GA
    Int J Cancer; 2002 Apr; 98(5):793-8. PubMed ID: 11920653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
    Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
    Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth.
    Zhao S; Zhao G; Xie H; Huang Y; Hou Y
    Braz J Med Biol Res; 2012 Mar; 45(3):230-7. PubMed ID: 22267001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.